Opioid Induced Constipation Overview
Learn About Opioid Induced Constipation
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Sarah Bush Lincoln Health Center
Nora Porter is a Nurse Practitioner in Mattoon, Illinois. Porter and is rated as an Experienced provider by MediFind in the treatment of Opioid Induced Constipation. Her top areas of expertise are Non-Alcoholic Fatty Liver Disease, Gallbladder Disease, Nonalcoholic Steatohepatitis (NASH), and Biliary Dyskinesia.
Midwest Emergency Department Specialists Ltd
David Kiel is a Family Medicine provider in Decatur, Illinois. Dr. Kiel has been practicing medicine for over 40 years and is rated as an Advanced provider by MediFind in the treatment of Opioid Induced Constipation. His top areas of expertise are Squamous Cell Lung Carcinoma, Small Cell Lung Cancer (SCLC), ALK-Positive Non-Small Cell Lung Cancer, and Lung Adenocarcinoma.
Decatur Memorial Hospital
Nathan Pyle is a Gastroenterologist in Decatur, Illinois. Dr. Pyle has been practicing medicine for over 14 years and is rated as an Advanced provider by MediFind in the treatment of Opioid Induced Constipation. His top areas of expertise are Ulcerative Colitis, Primary Biliary Cholangitis, Reynolds Syndrome, Endoscopy, and Gastrectomy.
Summary: Constipation is common (40-90%) in advanced cancer patients , and has a significant negative impact on quality of life. The aetiology of constipation is often multifactorial in advanced cancer patients. However, it is well recognised that opioid analgesics are a common cause of constipation in this group. The prevalence of opioid-induced constipation (OIC) is stated to be 40-70%, although a recent...
Summary: The research objective is to characterize the risk of a major adverse cardiovascular event (MACE) among new users of naldemedine versus new users of lubiprostone and new users of naloxegol as comparator opioid induced constipation (OIC) medications.